Hopman Mark bought BBNX
February 27, 2026 · Form 4 insider transaction
Hopman Mark bought 58,749 shares of Beta Bionics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,749
Price
$0.00
Total value
N/A
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after58,749
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.